168 related articles for article (PubMed ID: 31772219)
1. Predictive and prognostic significance of telomerase levels/telomere length in tissues and peripheral blood in head and neck squamous cell carcinoma.
Boscolo-Rizzo P; Rampazzo E; Polesel J; Giunco S; Menegaldo A; Mantovani M; Stellin M; Bandolin L; Spinato G; Del Mistro A; Borsetto D; Fussey J; Tirelli G; Da Mosto MC; De Rossi A
Sci Rep; 2019 Nov; 9(1):17572. PubMed ID: 31772219
[TBL] [Abstract][Full Text] [Related]
2. Telomere shortening in mucosa surrounding the tumor: biosensor of field cancerization and prognostic marker of mucosal failure in head and neck squamous cell carcinoma.
Boscolo-Rizzo P; Rampazzo E; Perissinotto E; Piano MA; Giunco S; Baboci L; Spinato G; Spinato R; Tirelli G; Da Mosto MC; Del Mistro A; De Rossi A
Oral Oncol; 2015 May; 51(5):500-7. PubMed ID: 25771075
[TBL] [Abstract][Full Text] [Related]
3. TERT promoter hotspot mutations and their relationship with TERT levels and telomere erosion in patients with head and neck squamous cell carcinoma.
Boscolo-Rizzo P; Giunco S; Rampazzo E; Brutti M; Spinato G; Menegaldo A; Stellin M; Mantovani M; Bandolin L; Rossi M; Del Mistro A; Tirelli G; Dei Tos AP; Guerriero A; Niero M; Da Mosto MC; Polesel J; De Rossi A
J Cancer Res Clin Oncol; 2020 Feb; 146(2):381-389. PubMed ID: 31960186
[TBL] [Abstract][Full Text] [Related]
4. Telomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications.
Boscolo-Rizzo P; Da Mosto MC; Rampazzo E; Giunco S; Del Mistro A; Menegaldo A; Baboci L; Mantovani M; Tirelli G; De Rossi A
Cancer Metastasis Rev; 2016 Sep; 35(3):457-74. PubMed ID: 27501725
[TBL] [Abstract][Full Text] [Related]
5. Clinical usefulness of telomerase activation and telomere length in head and neck cancer.
Patel MM; Parekh LJ; Jha FP; Sainger RN; Patel JB; Patel DD; Shah PM; Patel PS
Head Neck; 2002 Dec; 24(12):1060-7. PubMed ID: 12454944
[TBL] [Abstract][Full Text] [Related]
6. Telomeric Repeat-Containing RNAs (TERRA) Decrease in Squamous Cell Carcinoma of the Head and Neck Is Associated with Worsened Clinical Outcome.
Vitelli V; Falvo P; G Nergadze S; Santagostino M; Khoriauli L; Pellanda P; Bertino G; Occhini A; Benazzo M; Morbini P; Paulli M; Porta C; Giulotto E
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29342094
[TBL] [Abstract][Full Text] [Related]
7. Alteration of serum lipid profile and its prognostic value in head and neck squamous cell carcinoma.
Li G; Da M; Zhang W; Wu H; Ye J; Chen J; Ma L; Gu N; Wu Y; Song X
J Oral Pathol Med; 2016 Mar; 45(3):167-72. PubMed ID: 26189546
[TBL] [Abstract][Full Text] [Related]
8. High-risk human papillomavirus infection associated with telomere elongation in patients with esophageal squamous cell carcinoma with poor prognosis.
Zhang DH; Chen JY; Hong CQ; Yi DQ; Wang F; Cui W
Cancer; 2014 Sep; 120(17):2673-83. PubMed ID: 24840723
[TBL] [Abstract][Full Text] [Related]
9. Telomerase as an independent prognostic factor in head and neck squamous cell carcinoma.
Liao CT; Tung-Chieh Chang J; Wang HM; Chen IH; Lin CY; Chen TM; Hsieh LL; Cheng AJ
Head Neck; 2004 Jun; 26(6):504-12. PubMed ID: 15162351
[TBL] [Abstract][Full Text] [Related]
10. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
Gertler R; Rosenberg R; Stricker D; Friederichs J; Hoos A; Werner M; Ulm K; Holzmann B; Nekarda H; Siewert JR
J Clin Oncol; 2004 May; 22(10):1807-14. PubMed ID: 15143073
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues.
Mao L; El-Naggar AK; Fan YH; Lee JS; Lippman SM; Kayser S; Lotan R; Hong WK
Cancer Res; 1996 Dec; 56(24):5600-4. PubMed ID: 8971162
[TBL] [Abstract][Full Text] [Related]
12. [Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma].
Wu F; Wu LL; Zhu LX
Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):29-32. PubMed ID: 28104030
[No Abstract] [Full Text] [Related]
13. Telomere length and telomerase subunits as diagnostic and prognostic biomarkers in Barrett carcinoma.
Gertler R; Doll D; Maak M; Feith M; Rosenberg R
Cancer; 2008 May; 112(10):2173-80. PubMed ID: 18348304
[TBL] [Abstract][Full Text] [Related]
14. Lower circulating platelet counts and antiplatelet therapy independently predict better outcomes in patients with head and neck squamous cell carcinoma.
Rachidi S; Wallace K; Day TA; Alberg AJ; Li Z
J Hematol Oncol; 2014 Sep; 7():65. PubMed ID: 25260646
[TBL] [Abstract][Full Text] [Related]
15. The role of TERT-CLPTM1L SNPs, hTERT expression and telomere length in the pathogenesis of oral squamous cell carcinoma.
Carkic J; Nikolic N; Radojevic-Skodric S; Kuzmanovic-Pficer J; Brajovic G; Antunovic M; Milasin J; Popovic B
J Oral Sci; 2016; 58(4):449-458. PubMed ID: 28025427
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of telomerase and its associate genes expression in the maintenance of telomere length in squamous cell carcinoma of the esophagus.
Hsu CP; Lee LW; Shai SE; Chen CY
World J Gastroenterol; 2005 Nov; 11(44):6941-7. PubMed ID: 16437597
[TBL] [Abstract][Full Text] [Related]
17. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of serum squamous cell carcinoma antigen in patients with head and neck cancer.
Imai R; Takenaka Y; Yasui T; Nakahara S; Yamamoto Y; Hanamoto A; Takemoto N; Fukusumi T; Cho H; Yamamoto M; Inohara H
Acta Otolaryngol; 2015 Mar; 135(3):295-301. PubMed ID: 25622661
[TBL] [Abstract][Full Text] [Related]
19. Telomere length and TERT functional polymorphisms are not associated with risk of squamous cell carcinoma of the head and neck.
Liu Z; Ma H; Wei S; Li G; Sturgis EM; Wei Q
Cancer Epidemiol Biomarkers Prev; 2011 Dec; 20(12):2642-5. PubMed ID: 21994403
[TBL] [Abstract][Full Text] [Related]
20. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
